Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2014

Open Access 01-12-2014 | Research

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?

Authors: Dirk Rades, Stefan Huttenlocher, Dagmar Hornung, Oliver Blanck, Steven E Schild, Dorothea Fischer

Published in: Radiation Oncology | Issue 1/2014

Login to get access

Abstract

Background

An important issue in palliative radiation oncology is the whether whole-brain radiotherapy should be added to radiosurgery when treating a limited number of brain metastases. To optimize personalized treatment of cancer patients with brain metastases, the value of whole-brain radiotherapy should be described separately for each tumor entity. This study investigated the role of whole-brain radiotherapy added to radiosurgery in breast cancer patients.

Methods

Fifty-eight patients with 1–3 brain metastases from breast cancer were included in this retrospective study. Of these patients, 30 were treated with radiosurgery alone and 28 with radiosurgery plus whole-brain radiotherapy. Both groups were compared for local control of the irradiated metastases, freedom from new brain metastases and survival. Furthermore, eight additional factors were analyzed including dose of radiosurgery, age at radiotherapy, Eastern Cooperative Oncology Group (ECOG) performance score, number of brain metastases, maximum diameter of all brain metastases, site of brain metastases, extra-cranial metastases and the time from breast cancer diagnosis to radiotherapy.

Results

The treatment regimen had no significant impact on local control in the univariate analysis (p = 0.59). Age ≤59 years showed a trend towards improved local control on univariate (p = 0.066) and multivariate analysis (p = 0.07). On univariate analysis, radiosurgery plus whole-brain radiotherapy (p = 0.040) and ECOG 0–1 (p = 0.012) showed positive associations with freedom from new brain metastases. Both treatment regimen (p = 0.039) and performance status (p = 0.028) maintained significance on multivariate analysis. ECOG 0–1 was positively correlated with survival on univariate analysis (p < 0.001); age ≤59 years showed a strong trend (p = 0.054). On multivariate analysis, performance status (p < 0.001) and age (p = 0.041) were significant.

Conclusions

In breast cancer patients with few brain metastases, radiosurgery plus whole-brain radiotherapy resulted in significantly better freedom from new brain metastases than radiosurgery alone. However, this advantage did not lead to significantly better survival.
Appendix
Available only for authorised users
Literature
1.
Khuntia D, Brown P, Li J, Mehta MP: Whole-brain radiotherapy in the management of brain metastases. J Clin Oncol. 2006, 24: 1295-1304. 10.1200/JCO.2005.04.6185.CrossRefPubMed
2.
Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE, Trang NT, Khoa MT: A simple survival score for patients with brain metastases from breast cancer. Strahlenther Onkol. 2013, 189: 664-667. 10.1007/s00066-013-0367-5.CrossRefPubMed
3.
Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, Schild SE, Trang NT, Khoa MT: A new survival score for patients with brain metastases from non-small cell lung cancer. Strahlenther Onkol. 2013, 189: 777-781. 10.1007/s00066-013-0362-x.CrossRefPubMed
4.
Schüttrumpf LH, Niyazi M, Nachbichler SB, Manapov F, Jansen N, Siefert A, Belka C: Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases. Radiat Oncol. 2014, 9: 105-10.1186/1748-717X-9-105.PubMedCentralCrossRefPubMed
5.
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009, 10: 1037-1044. 10.1016/S1470-2045(09)70263-3.CrossRefPubMed
6.
Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol. 2011, 29: 134-141. 10.1200/JCO.2010.30.1655.PubMedCentralCrossRefPubMed
7.
Aoyama H, Shirato H, Tago M, Nakadawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Horota S, Snioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA. 2006, 295: 2483-2491. 10.1001/jama.295.21.2483.CrossRefPubMed
8.
Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010, 77: 655-661. 10.1016/j.ijrobp.2009.08.025.CrossRefPubMed
9.
Jo KI, Im YH, Kong DS, Seol HJ, Nam DH, Lee JI: Gamma knife radiosurgery for brain metastases from breast cancer. J Korean Neurosurg Soc. 2013, 54: 399-404. 10.3340/jkns.2013.54.5.399.PubMedCentralCrossRefPubMed
10.
Maclean J, Fersht N, Singhera M, Mulholland P, McKee O, Kitchen N, Short SC: Multi-disciplinary management for patients with oligometastases to the brain: results of a 5 year cohort study. Radiat Oncol. 2013, 8: 156-10.1186/1748-717X-8-156.PubMedCentralCrossRefPubMed
11.
Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007, 68: 1388-1395. 10.1016/j.ijrobp.2007.03.048.CrossRefPubMed
12.
Regine WF, Scott C, Murray K, Curran W: Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91–04. Int J Radiat Oncol Biol Phys. 2001, 51: 711-717. 10.1016/S0360-3016(01)01676-5.CrossRefPubMed
13.
Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004, 22: 157-165. 10.1200/JCO.2004.05.128.CrossRefPubMed
14.
Huttenlocher S, Dziggel L, Hornung D, Blanck O, Schild SE, Rades D: A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone. Radiat Oncol. 2014, 9: 215-10.1186/1748-717X-9-215.PubMedCentralCrossRefPubMed
15.
Choi SW, Kwon do H, Kim CJ: Clinical outcome in gamma knife radiosurgery for metastatic brain tumors from the primary breast cancer: prognostic factors in local treatment failure and survival. J Korean Neurosurg Soc. 2013, 54: 329-335. 10.3340/jkns.2013.54.4.329.PubMedCentralCrossRefPubMed
16.
Jaboin JJ, Ferraro DJ, DeWees TA, Rich KM, Chicoine MR, Dowling JL, Mansur DB, Drzymala RE, Simpson JR, Magnuson WJ, Patel AH, Zoberi I: Survival following gamma knife radiosurgery for brain metastasis from breast cancer. Radiat Oncol. 2013, 8: 131-10.1186/1748-717X-8-131.PubMedCentralCrossRefPubMed
Metadata
Title
Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
Authors
Dirk Rades
Stefan Huttenlocher
Dagmar Hornung
Oliver Blanck
Steven E Schild
Dorothea Fischer
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2014
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-014-0267-6

Other articles of this Issue 1/2014

Radiation Oncology 1/2014 Go to the issue

Case report

Prominent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: a case report

Research

Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results

Research

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

Research

BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

Research

Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy

Research

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer